(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -90.37%-1M | -526.52K |
Payments to suppliers for goods and services | -90.37%-1M | ---526.52K |
Direct interest received | --5.28K | ---- |
Operating cash flow | -89.37%-997.07K | ---526.52K |
Investing cash flow | ||
Cash flow from continuing investing activities | -1,688.31%-1.63M | -91.22K |
Capital expenditure reported | -2,134.20%-1.52M | ---68.03K |
Net PPE purchase and sale | -52.65%-27.76K | ---18.19K |
Net investment purchase and sale | ---83.55K | ---- |
Net other investing changes | ---- | ---5K |
Cash from discontinued investing activities | ||
Investing cash flow | -1,688.31%-1.63M | ---91.22K |
Financing cash flow | ||
Cash flow from continuing financing activities | -26.51%3.57M | 4.86M |
Net common stock issuance | -26.51%3.57M | --4.86M |
Cash from discontinued financing activities | ||
Financing cash flow | -26.51%3.57M | --4.86M |
Net cash flow | ||
Beginning cash position | --4.24M | ---- |
Current changes in cash | -77.75%944.04K | --4.24M |
End cash Position | 22.25%5.19M | --4.24M |
Free cash from | -315.32%-2.54M | ---612.75K |
Accounting Standards | US-GAAP | US-GAAP |
No Data